Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Broekman

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Human Genetics|September 5, 2014
GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel diseaseMark M T J Broekman, Caro Bos, René H M Te Morsche, et al.
Cell Biology and Toxicology|April 29, 2015
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitroMark M T J Broekman, Hennie M J Roelofs, Dennis R Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2009
Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotypeWietske A Ester, Hermine A van Duyvenvoorde, Caroline C de Wit, et al.
The Journal of Clinical Investigation|March 15, 1997
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39A J Marcus, M J Broekman, J H Drosopoulos, et al.
The Netherlands Journal of Medicine|September 17, 2013
Treatment of hepatitis C monoinfection in adults--Dutch national guidelinesM H Lamers, M M T J Broekman, C A Boucher, et al.
The Journal of Clinical Investigation|June 13, 1998
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39R B Gayle, C R Maliszewski, S D Gimpel, et al.
Peerj|May 3, 2013
Phenotypic characterization of patients with deletions in the 3'-flanking SHOX regionSarina G Kant, Sander J Broekman, Caroline C de Wit, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2017
Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotypeM M T J Broekman, M J H Coenen, G J Wanten, et al.
Pharmacogenetics and Genomics|December 8, 2016
Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control studyMark W Hess, Jeroen H F de Baaij, Mark M T J Broekman, et al.
Inflammatory Bowel Diseases|June 24, 2017
More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher DosingMark M T J Broekman, Marieke J H Coenen, Corine J van Marrewijk, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Human Genetics|September 5, 2014
GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel diseaseMark M T J Broekman, Caro Bos, René H M Te Morsche, et al.
Cell Biology and Toxicology|April 29, 2015
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitroMark M T J Broekman, Hennie M J Roelofs, Dennis R Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2009
Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotypeWietske A Ester, Hermine A van Duyvenvoorde, Caroline C de Wit, et al.
The Journal of Clinical Investigation|March 15, 1997
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39A J Marcus, M J Broekman, J H Drosopoulos, et al.
The Netherlands Journal of Medicine|September 17, 2013
Treatment of hepatitis C monoinfection in adults--Dutch national guidelinesM H Lamers, M M T J Broekman, C A Boucher, et al.
The Journal of Clinical Investigation|June 13, 1998
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39R B Gayle, C R Maliszewski, S D Gimpel, et al.
Peerj|May 3, 2013
Phenotypic characterization of patients with deletions in the 3'-flanking SHOX regionSarina G Kant, Sander J Broekman, Caroline C de Wit, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2017
Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotypeM M T J Broekman, M J H Coenen, G J Wanten, et al.
Pharmacogenetics and Genomics|December 8, 2016
Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control studyMark W Hess, Jeroen H F de Baaij, Mark M T J Broekman, et al.
Inflammatory Bowel Diseases|June 24, 2017
More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher DosingMark M T J Broekman, Marieke J H Coenen, Corine J van Marrewijk, et al.
Pageof 9